Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Secretary of State for Health and Social Care acting as part of the Crown through the Department of Health and Social Care
2nd Floor, Rutland House
Runcorn
WA7 2ES
UK
E-mail: john.cook@dh.gsi.gov.uk
NUTS: UK
Internet address(es)
Main address: https://dh.bravosolution.co.uk
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Antivirals for Use in an Influenza Pandemic, or Wide Scale Epidemic
Reference number: CM/EMI/16/5505
II.1.2) Main CPV code
33651400
II.1.3) Type of contract
Supplies
II.1.4) Short description
Procurement exercise for a contract(s) for the supply of antivirals suitable for use in an influenza pandemic, or a wide scale epidemic. Deliveries will be required over a maximum period of 6 years (including extension options).
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
1.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
Oseltamivir Capsules (30 mg, 45 mg and 75 mg) for the Treatment of Patients Aged 1 Year and Over
II.2.2) Additional CPV code(s)
33651400
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The authority will use any resulting contracts to maintain a stockpile of products in the range of 23-38 m treatment courses across all 4 lots.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 12
Quality criterion: Timeliness
/ Weighting: 12
Quality criterion: Product quality
/ Weighting: 10
Quality criterion: Acceptance of the conditions of contract
/ Weighting: 30
Cost criterion: Whole life cost
/ Weighting: 36
II.2.11) Information about options
Options:
Yes
Description of options:
The contract duration includes 2 x 12 month extension options.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Oseltamivir Suspension for the Treatment of Patients Aged 1 Year and Under
II.2.2) Additional CPV code(s)
33651400
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The authority will use any resulting contracts to maintain a stockpile of products in the range of 23-38 m treatment courses across all 4 lots.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 12
Quality criterion: Timeliness
/ Weighting: 12
Quality criterion: Product quality
/ Weighting: 10
Quality criterion: Acceptance of the conditions of contract
/ Weighting: 30
Cost criterion: Whole life cost
/ Weighting: 36
II.2.11) Information about options
Options:
Yes
Description of options:
The contract duration includes 3 x 12 month extension options.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Oseltamivir Phosphate Powder (Active Pharmaceutical Ingredient (API)) Used for the Manufacture of a Solution for Patients Aged 1 Year and Under
II.2.2) Additional CPV code(s)
33651400
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The authority will use any resulting contracts to maintain a stockpile of products in the range of 23-38 m treatment courses across all 4 lots.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 12
Quality criterion: Timeliness
/ Weighting: 12
Quality criterion: Product quality
/ Weighting: 10
Quality criterion: Acceptance of the conditions of contract
/ Weighting: 30
Cost criterion: Whole life cost
/ Weighting: 36
II.2.11) Information about options
Options:
Yes
Description of options:
The contract duration includes three 12 month extension options.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
Zanamivir Inhalers for the Treatment of Patients Aged 5 Years and Over
II.2.2) Additional CPV code(s)
33651400
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The authority will use any resulting contracts to maintain a stockpile of products in the range of 23-38 m treatment courses across all 4 lots.
II.2.5) Award criteria
Quality criterion: Supply chain
/ Weighting: 12
Quality criterion: Timeliness
/ Weighting: 12
Quality criterion: Product quality
/ Weighting: 10
Quality criterion: Acceptance of the conditions of contract
/ Weighting: 30
Cost criterion: Whole life cost
/ Weighting: 36
II.2.11) Information about options
Options:
Yes
Description of options:
The contract duration includes three 12 month extension options.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Competitive procedure with negotiation
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2017/S 197-404524
Section V: Award of contract
Lot No: 1
Title: Oseltamivir Capsules (30 mg, 45 mg and 75 mg) for the Treatment of Patients Aged 1 Year and Over
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
20/09/2018
V.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Roche Products Ltd
Welwyn Garden City
UK
NUTS: UKH23
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 2
Title: Oseltamivir Suspension for the Treatment of Patients Aged 1 Year and Under
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
20/09/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Roche Products Ltd
Welwyn Garden City
UK
NUTS: UKH23
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 3
Title: Oseltamivir Phosphate Powder (Active Pharmaceutical Ingredient (API)) Used for the Manufacture of a Solution for Patients Aged 1 Year and Under
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
20/09/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Roche Products Ltd
Welwyn Garden City
UK
NUTS: UKH23
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 4
Title: Zanamivir Inhalers for the Treatment of Patients Aged 5 Years and Over
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
20/09/2018
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
GlaxoSmithKline Ltd
Brentford
UK
NUTS: UKI
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 1.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
Other Contracting Authorities
The contract(s) is for the benefit of the Contracting Authority and NHS bodies along with any other non-NHS bodies which are necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services in the United Kingdom, Crown Dependencies and British Overseas Territories including, without limitation, the National Assembly for Wales, the Northern Ireland Assembly, and Scottish Ministers. The resulting products delivered against the contract(s) may be made available to the UK devolved administrations, Crown Dependencies and British Overseas Territories.
VI.4) Procedures for review
VI.4.1) Review body
The Secretary of State for Health acting as part of the Crown through the Department of Health and Social Care
Runcorn
UK
VI.5) Date of dispatch of this notice
31/10/2018